| CAS NO: | 2101314-20-7 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| CAS： | 2101314-20-7 |
| 分子式： | C27H28ClN7O2S |
| 分子量： | 550.07 |
| 纯度： | ≥98% |
| 溶解性： | DMSO |
| 存储： | Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month |
| 研究领域： | Cancer |
| Target： | IC50: 54 nM (rRNA synthesis, MIA PaCa-2 cells), 113 nM (rRNA synthesis, A375 cells), 142 nM (rRNA synthesis, HCT-116 cells)[1] |
| 描述： | CX-5416 HCl is a potent and orally bioavailable inhibitor of Pol I-mediated rRNA synthesis, with IC50 of 142 nM in HCT-116, 113 nM in A375, and 54 nM in MIA PaCa-2 cells, and shows little or no effect |
m.cnreagent.com